Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome. 1997

F E Visser, and A P Aldenkamp, and A C van Huffelen, and M Kuilman, and J Overweg, and J van Wijk
's-Heeren Loo-Lozenoord, Centre for the Intellectually Disabled, Ermelo, The Netherlands.

Institutionalized patients with Down syndrome (n = 307) were monitored for 5 to 10 years prospectively to determine prevalence of Alzheimer-type dementia. Clinical signs, cognitive functioning, and EEGs were assessed. When possible, postmortem neuropathological examinations were conducted. Progressive mental and physical deterioration was found for 56 of the residents. Mean age at onset of dementia was 56 years. Prevalence increased from 11% between ages 40 and 49 to 77% between 60 and 69. All patients 70 and over had dementia. Neuropathological findings were consistent with clinical diagnosis. Use of a dementia checklist, cognitive skills inventory, and EEG reliably detected Alzheimer-type dementia at an early stage.

UI MeSH Term Description Entries
D007326 Institutionalization The caring for individuals in institutions and their adaptation to routines characteristic of the institutional environment, and/or their loss of adaptation to life outside the institution. Institutionalized Persons,Institutionalizations,Institutionalized Person,Person, Institutionalized,Persons, Institutionalized
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009426 Netherlands Country located in EUROPE. It is bordered by the NORTH SEA, BELGIUM, and GERMANY. Constituent areas are Aruba, Curacao, and Sint Maarten, formerly included in the NETHERLANDS ANTILLES. Holland,Kingdom of the Netherlands
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004314 Down Syndrome A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) Mongolism,Trisomy 21,47,XX,+21,47,XY,+21,Down Syndrome, Partial Trisomy 21,Down's Syndrome,Partial Trisomy 21 Down Syndrome,Trisomy 21, Meiotic Nondisjunction,Trisomy 21, Mitotic Nondisjunction,Trisomy G,Downs Syndrome,Syndrome, Down,Syndrome, Down's
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F E Visser, and A P Aldenkamp, and A C van Huffelen, and M Kuilman, and J Overweg, and J van Wijk
February 1995, Ugeskrift for laeger,
F E Visser, and A P Aldenkamp, and A C van Huffelen, and M Kuilman, and J Overweg, and J van Wijk
February 2020, JAMA neurology,
F E Visser, and A P Aldenkamp, and A C van Huffelen, and M Kuilman, and J Overweg, and J van Wijk
July 1981, Lancet (London, England),
F E Visser, and A P Aldenkamp, and A C van Huffelen, and M Kuilman, and J Overweg, and J van Wijk
February 2019, JAMA neurology,
F E Visser, and A P Aldenkamp, and A C van Huffelen, and M Kuilman, and J Overweg, and J van Wijk
November 1998, International journal of geriatric psychiatry,
F E Visser, and A P Aldenkamp, and A C van Huffelen, and M Kuilman, and J Overweg, and J van Wijk
March 1985, American journal of mental deficiency,
F E Visser, and A P Aldenkamp, and A C van Huffelen, and M Kuilman, and J Overweg, and J van Wijk
September 2022, Fortschritte der Neurologie-Psychiatrie,
F E Visser, and A P Aldenkamp, and A C van Huffelen, and M Kuilman, and J Overweg, and J van Wijk
August 1989, Archives of neurology,
F E Visser, and A P Aldenkamp, and A C van Huffelen, and M Kuilman, and J Overweg, and J van Wijk
May 1995, American journal of mental retardation : AJMR,
F E Visser, and A P Aldenkamp, and A C van Huffelen, and M Kuilman, and J Overweg, and J van Wijk
January 2003, The journal of nutrition, health & aging,
Copied contents to your clipboard!